(Q38304282)

1 September 2017

A novel tyrosine kinase switch is a mechanism of imatinib resistance in gastrointestinal stromal tumors (English)

1 reference

1 September 2017

1 reference

12

1 reference

1 September 2017

D Mahadevan

1

1 reference

1 September 2017

L Cooke

2

1 reference

1 September 2017

C Riley

3

1 reference

1 September 2017

R Swart

4

1 reference

1 September 2017

B Simons

5

1 reference

1 September 2017

K Della Croce

6

1 reference

1 September 2017

L Wisner

7

1 reference

1 September 2017

M Iorio

8

1 reference

1 September 2017

K Shakalya

9

1 reference

1 September 2017

H Garewal

10

1 reference

1 September 2017

R Nagle

11

1 reference

1 September 2017

language of work or name

English

0 references

publication date

26 February 2007

1 reference

1 September 2017

1 reference

1 September 2017

26

1 reference

1 September 2017

3909-3919

1 reference

1 September 2017

27

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1210173

1 September 2017

0 references

cites work

Molecular characterization of the tumor microenvironment in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210173

The plasminogen activation system in tumor growth, invasion, and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210173

Acquired resistance to imatinib in gastrointestinal stromal tumor occurs through secondary gene mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210173

Identification of Gas6 as a ligand for Mer, a neural cell adhesion molecule related receptor tyrosine kinase implicated in cellular transformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210173

Imatinib resistance in gastrointestinal stromal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210173

A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210173

Biology of gastrointestinal stromal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210173

Neural cell adhesion molecule: structure, immunoglobulin-like domains, cell surface modulation, and alternative RNA splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210173

Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210173

Clinical management of gastrointestinal stromal tumors: before and after STI-571.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210173

Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210173

Gastrointestinal stromal tumors: biology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210173

PDGFRA activating mutations in gastrointestinal stromal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210173

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210173

Multiple roles for the receptor tyrosine kinase axl in tumor formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210173

Enhanced genome annotation using structural profiles in the program 3D-PSSM

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210173

Kit as a human oncogenic tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210173

Tumour biological aspects of CD24, a mucin-like adhesion molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210173

PROCHECK: a program to check the stereochemical quality of protein structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210173

Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210173

Imatinib binding and cKIT inhibition is abrogated by the cKIT kinase domain I missense mutation Val654Ala

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210173

Targeting the tumor and its microenvironment by a dual-function decoy Met receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210173

Structural basis for the autoinhibition and STI-571 inhibition of c-Kit tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210173

Structure of a c-kit product complex reveals the basis for kinase transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210173

axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210173

Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-Met and its complex with the microbial alkaloid K-252a

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210173

Identification of BMP and activin membrane-bound inhibitor (BAMBI), an inhibitor of transforming growth factor-beta signaling, as a target of the beta-catenin pathway in colorectal tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210173

The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210173

Multidrug resistance proteins in gastrointestinal stromal tumors: site-dependent expression and initial response to imatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210173

STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210173

Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210173

The effect of antimicrotubule agents on signal transduction pathways of apoptosis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210173

Neuroectodermal differentiation of the gastrointestinal tumors in the Carney triad. An ultrastructural and immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210173

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.ONC.1210173

1 reference

Dimensions Publication ID

1 September 2017

0 references

1 reference